Free Cash Flow Build Up

Cassava Sciences, Inc. (SAVA)

$ 84.77
4.88 (+6.10%)
Year
A/P
2013
Actual
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 41.12------------
EBITDA 31.37------------
EBIT -------------
Tax Rate -0.23%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.03%-0.03%-0.03%-0.03%-0.03%
EBIAT -------------
Depreciation -------------
Accounts Receivable -------------
Inventories -------------
Accounts Payable -------------
Capital Expenditure --0.08-0.20-0.07---0.02-0.35-----
UFCF -------------
WACC
PV UFCF ------------
SUM PV UFCF -